Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase‑4 gene expression by Smads during transforming growth factor β‑induced epithelial‑mesenchymal transition

Guo,Jia; Song,Bo; Li,Xiang; Hε,Chenhui; Yang,Ganglong; Yang,Xiaomin; Guan,Feng

doi:10.3892/mmr.2014.2912

Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase‑4 gene expression by Smads during transforming growth factor β‑induced epithelial‑mesenchymal transition

Authors:
- Jia Guo
- Bo Song
- Xiang Li
- Chenhui Hε
- Ganglong Yang
- Xiaomin Yang
- Feng Guan
View Affiliations

Affiliations: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, Department of Oncological Surgery, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, P.R. China
Published online on: November 10, 2014 https://doi.org/10.3892/mmr.2014.2912
Pages: 2241-2247

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The process of epithelial‑mesenchymal transition (EMT) is essential for the proliferation and metastasis of tumor cells. Our previous study demonstrated that the expression of gangliotetraosylceramide (Gg4) and the transcription of UDP‑Gal: β1,3-galactosyltransferase‑4 (β3GalT4), a gene which controls the expression of Gg4, are reduced during transforming growth factor (TGF)‑β‑induced EMT in normal murine mammary gland (NMuMG) cells. The present study revealed that the transcription level of β3GalT4 in patients with breast cancer was decreased compared with healthy control subjects. However, the molecular basis underlying these effects remains to be elucidated. Analysis of the β3GalT4 promoter sequence revealed a putative Smad‑binding element (SBE) of Smad4, which is a transcriptional factor in TGFβ responses and forms a complex with Smad3. To clarify the association between the Smad3/4 complex and the β3GalT4 gene during EMT in NMuMG cells, an electrophoretic mobility shift assay and a chromatin immunoprecipitation assay were performed. The Smad3/4 complex was found to bind directly to the SBE of the β3GalT4 promoter. Overexpression of Smad3 and Smad4 through stable transfection had no notable effect on cell phenotype, but did alter the expression of various EMT protein markers. Treatment with TGFβ reduced the expression of Gg4 and the mRNA levels of the β3GalT4 gene in Smad3‑ and Smad4‑overexpressing cells compared with vector‑transfected cells. Expression of the epithelial markers E‑cadherin and β‑catenin decreased in parallel with the reduction in Gg4. These findings suggested that the activated Smad3/4 complex downregulated the expression of Gg4 and the β3GalT4 gene through translocation into the nucleus and binding to the β3GalT4 promoter.

View Figures

View References

1	Yamashita T, Wada R, Sasaki T, et al: A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA. 96:9142–9147. 1999. View Article : Google Scholar : PubMed/NCBI
2	Zeng G, Gao L, Birkle S and Yu RK: Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60:6670–6676. 2000.PubMed/NCBI
3	Zeng G, Gao L and Yu RK: Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed. Int J Cancer. 88:53–57. 2000. View Article : Google Scholar : PubMed/NCBI
4	Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56:5309–5318. 1996.PubMed/NCBI
5	Hakomori S: Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 99:10231–10233. 2002. View Article : Google Scholar : PubMed/NCBI
6	Allende ML and Proia RL: Lubricating cell signaling pathways with gangliosides. Curr Opin Struct Biol. 12:587–592. 2002. View Article : Google Scholar : PubMed/NCBI
7	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
8	Quaggin SE and Kapus A: Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int. 80:41–50. 2011. View Article : Google Scholar : PubMed/NCBI
9	Guan F, Schaffer L, Handa K and Hakomori SI: Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-(beta). FASEB J. 24:4889–4903. 2010. View Article : Google Scholar : PubMed/NCBI
10	Guan F, Handa K and Hakomori SI: Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA. 106:7461–7466. 2009. View Article : Google Scholar : PubMed/NCBI
11	Shi Y and Massagué J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
12	Xu L and Massagué J: Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol. 5:209–219. 2004. View Article : Google Scholar : PubMed/NCBI
13	Kang JS, Liu C and Derynck R: New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol. 19:385–394. 2009. View Article : Google Scholar : PubMed/NCBI
14	Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
15	Zawel L, Dai JL, Buckhaults P, et al: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1:611–617. 1998. View Article : Google Scholar : PubMed/NCBI
16	Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J and Pavletich NP: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell. 94:585–594. 1998. View Article : Google Scholar : PubMed/NCBI
17	Xia T, Gao L, Yu RK and Zeng G: Characterization of the promoter and the transcription factors for the mouse UDP-Gal:betaGlcNAc beta1,3-galactosyltransferase gene. Gene. 309:117–123. 2003. View Article : Google Scholar : PubMed/NCBI
18	Nelson EA, Walker SR, Alvarez JV and Frank DA: Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem. 279:54724–54730. 2004. View Article : Google Scholar : PubMed/NCBI
19	Todeschini AR, Dos Santos JN, Handa K and Hakomori SI: Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem. 282:8123–8133. 2007. View Article : Google Scholar : PubMed/NCBI
20	Pierreux CE, Nicolás FJ and Hill CS: Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol. 20:9041–9054. 2000. View Article : Google Scholar : PubMed/NCBI
21	Schmierer B and Hill CS: Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol Cell Biol. 25:9845–9858. 2005. View Article : Google Scholar : PubMed/NCBI
22	Hill CS: Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 19:36–46. 2009. View Article : Google Scholar
23	Inman GJ, Nicolas FJ and Hill CS: Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell. 10:283–294. 2002. View Article : Google Scholar : PubMed/NCBI
24	Nieman MT, Prudoff RS, Johnson KR and Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 147:631–644. 1999. View Article : Google Scholar : PubMed/NCBI
25	Conacci-Sorrell M, Zhurinsky J and Ben-Ze’ev A: The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 109:987–991. 2002. View Article : Google Scholar : PubMed/NCBI
26	Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI